Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Veterinary Biologics Market from 2024 to 2025?

The market size for veterinary biologics has witnessed substantial growth over the past few years. Financial growth from $12.67 billion in 2024 to $13.65 billion in 2025, with a compound annual growth rate (CAGR) of 7.7%, is forecasted. Animal disease epidemics, regulatory encouragement and standards, the need for food security, trade globalization, and the financial importance of livestock are factors that contributed to the growth during the historic era.

What Is the Projected Market Size of the Veterinary Biologics Market?

In the forthcoming years, the veterinary biologics market is projected to witness robust growth. It is set to escalate to a value of $18.38 billion by 2029, with a compound annual growth rate (CAGR) of 7.7%. This projected growth within the forecast period is related to factors such as the emergence of infectious diseases, changes in climatic conditions and disease patterns, precision livestock farming, the implementation of a one health approach, and the rising trend of pet ownership. The forecast period is likely to see major trends like educational and training programs, sustainable and eco-friendly biologics, incorporation of digital health records, growth in companion animal biologics, and therapies that are targeted and customized.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12366&type=smp

Who are the Major Competitors in the Veterinary Biologics Market Outlook?

Major companies operating in the veterinary biologics market include Bayer AG, Eli Lilly & Company, Evonik Industries AG, Zoetis Inc., Merck Animal Health Inc., Boehringer Ingelheim Animal Health Inc., Elanco Animal Health, IDEXX Laboratories Inc., Virbac SA, Phibro Animal Health Corporation, Vetoquinol, Abaxis Inc., Bimeda Biologicals, Ceva Sante Animale S.A., Heska Corporation, Colorado Serum Company, Hester Biosciences Limited, INDICAL Bioscience GmbH, Ambrx Biopharma Inc., Adamis Pharmaceuticals Corporation, Intervet Inc., Hebei Veyong Animal Pharmaceutical Co. Ltd., FidoCure, Biomet Biologics LLC, CytoDyn Veterinary Medicine LLC, KM Biologics

What Is Fueling Growth in the Veterinary Biologics Market?

The increased prevalence of diseases among animals is forecasted to stimulate the expansion of the veterinary biologics market. Animal diseases, which encompass various forms of illnesses and health issues among several animal breeds, can be managed better with enhanced diagnosis and treatment. This is where veterinary biologics come into play, with their immunological methods offering effective solutions to combat animal diseases. For example, as per records from the Europe-based health agency, the European Center for Disease Prevention and Control in October 2022, a shocking 2,467 instances of avian influenza outbreaks in poultry, affecting 48 million birds, were documented, including 187 cases within captive birds. Additionally, based on information provided by the World Health Organization, a UN-specialized agency situated in Switzerland, in July 2022, rabies is responsible for the death of 59,000 individuals yearly across more than 150 countries, with the majority of cases, 95%, being reported in Africa and Asia. Therefore, the escalating figures of animal diseases corroborate the rising demand for veterinary biologics.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12366&type=smp

Which Veterinary Biologics Market Segments Are Growing the Fastest?

The veterinary biologics market covered in this report is segmented –

1) By Product: Vaccines, Diagnostic Kits, Immunomodulators, Antiserums And Antibodies, Other Products

2) By Disease Type: Bluetongue, Foot And Mouth Disease, Brucellosis And Tuberculosis, Other Diseases

3) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Other Distribution Channels

4) By Application: Production Animal, Companion Animal

Subsegments:

1) By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, DNA Vaccines

2) By Diagnostic Kits: Rapid Tests, Elisa Kits, Pcr-Based Diagnostic Kits

3) By Immunomodulators: Cytokines, Adjuvants, Immunostimulants

4) By Antiserums And Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Hyperimmune Serums

5) By Other Products: Probiotics, Prebiotics, Growth Factors, Toxoids

Which Industry Trends Are Shaping the Future of the Veterinary Biologics Market?

Significant enterprises within the veterinary biologics market sector are concentrating their resources on creating innovative biologics such as vaccines. These vaccines are pivotal in boosting animal well-being and forestalling diseases. Vaccines function by prompting the immune system to identify and combat specific disease-causing agents, thereby preventing infectious diseases by fostering acquired immunity. Illustratively, Merck Animal Health, a leading animal health corporation based in the US, officially introduced an autogenous vaccine for avian metapneumovirus (aMPV) type B in August 2024. This was following its approval by the U.S Department of Agriculture (USDA) to be both produced and sold. This vaccine, a product of a strategic partnership with Cambridge Technologies, is designed to tackle severe respiratory problems related to aMPV type B in poultry. These health problems had been causing substantial economic losses since late 2023. The vaccine is made in a cutting-edge Minnesota facility and features an oil and water emulsion formulation, specifically designed to reduce tissue reactions after vaccination. This presents a solution to a critical void in the market as there were no other commercially registered vaccines available previously.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/veterinary-biologics-global-market-report

Which Countries Are Leading the Veterinary Biologics Market?

North America was the largest region in the veterinary biologics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12366

This Report Delivers Insight On:

1. How big is the veterinary biologics market, and how is it changing globally?

2. Who are the major companies in the veterinary biologics market, and how are they performing?

3. What are the key opportunities and risks in the veterinary biologics market right now?

4. Which products or customer segments are growing the most in the veterinary biologics market?

5. What factors are helping or slowing down the growth of the veterinary biologics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model